Belinda_Cowling
Belinda Cowling
French medical researcher
Belinda S. Cowling is a French medical researcher and cofounder and scientific advisor of the biotech firm Dynacure, which was founded in 2016. She became Head of Research in 2018, responsible for the company’s R&D strategy, and leading Dynacure’s research programs in centronuclear myopathy (CNM) and other disease domains. As Dynacure's Chief Scientific Officer,[1] her focus is on translational research and drug-candidate development.[2] In 2019, she was awarded the Irène Joliot-Curie Prize in the category: Women, Research and Enterprise.[3]